vs
Side-by-side financial comparison of RADIANT LOGISTICS, INC (RLGT) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $232.1M, roughly 1.3× RADIANT LOGISTICS, INC). Bio-Techne runs the higher net margin — 12.8% vs 2.3%, a 10.6% gap on every dollar of revenue. On growth, Bio-Techne posted the faster year-over-year revenue change (-6.4% vs -12.3%). Over the past eight quarters, RADIANT LOGISTICS, INC's revenue compounded faster (12.1% CAGR vs 4.2%).
Radiant Logistics, Inc. is a leading third-party logistics provider offering end-to-end supply chain solutions, domestic and international freight forwarding, warehousing, and last-mile delivery services. It primarily serves North American markets, with key client segments including retail, manufacturing, e-commerce, and industrial sectors, helping businesses optimize logistics workflows and cut operational costs.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
RLGT vs TECH — Head-to-Head
Income Statement — Q2 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $232.1M | $295.9M |
| Net Profit | $5.3M | $38.0M |
| Gross Margin | — | 64.6% |
| Operating Margin | 3.2% | 18.4% |
| Net Margin | 2.3% | 12.8% |
| Revenue YoY | -12.3% | -6.4% |
| Net Profit YoY | -18.0% | 68.3% |
| EPS (diluted) | $0.11 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $232.1M | $295.9M | ||
| Q3 25 | $226.7M | — | ||
| Q2 25 | $220.6M | $317.0M | ||
| Q1 25 | $214.0M | $316.2M | ||
| Q4 24 | $264.5M | $297.0M | ||
| Q3 24 | $203.6M | $289.5M | ||
| Q2 24 | $206.0M | $306.1M | ||
| Q1 24 | $184.6M | $303.4M |
| Q4 25 | $5.3M | $38.0M | ||
| Q3 25 | $1.3M | — | ||
| Q2 25 | $4.9M | $-17.7M | ||
| Q1 25 | $2.5M | $22.6M | ||
| Q4 24 | $6.5M | $34.9M | ||
| Q3 24 | $3.4M | $33.6M | ||
| Q2 24 | $4.8M | $40.6M | ||
| Q1 24 | $-703.0K | $49.1M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% | ||
| Q1 24 | — | 67.4% |
| Q4 25 | 3.2% | 18.4% | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | 2.4% | -7.5% | ||
| Q1 25 | 1.6% | 12.2% | ||
| Q4 24 | 3.3% | 16.0% | ||
| Q3 24 | 1.9% | 13.8% | ||
| Q2 24 | 2.4% | 15.0% | ||
| Q1 24 | -0.5% | 22.1% |
| Q4 25 | 2.3% | 12.8% | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | 2.2% | -5.6% | ||
| Q1 25 | 1.2% | 7.1% | ||
| Q4 24 | 2.4% | 11.7% | ||
| Q3 24 | 1.7% | 11.6% | ||
| Q2 24 | 2.3% | 13.3% | ||
| Q1 24 | -0.4% | 16.2% |
| Q4 25 | $0.11 | $0.24 | ||
| Q3 25 | $0.03 | — | ||
| Q2 25 | $0.10 | $-0.11 | ||
| Q1 25 | $0.05 | $0.14 | ||
| Q4 24 | $0.13 | $0.22 | ||
| Q3 24 | $0.07 | $0.21 | ||
| Q2 24 | $0.11 | $0.26 | ||
| Q1 24 | $-0.02 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.9M | $172.9M |
| Total DebtLower is stronger | — | $260.0M |
| Stockholders' EquityBook value | $229.8M | $2.0B |
| Total Assets | $439.4M | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.9M | $172.9M | ||
| Q3 25 | $28.1M | — | ||
| Q2 25 | $22.9M | $162.2M | ||
| Q1 25 | $19.0M | $140.7M | ||
| Q4 24 | $19.9M | $177.5M | ||
| Q3 24 | $10.4M | $187.5M | ||
| Q2 24 | $24.9M | $152.9M | ||
| Q1 24 | $31.2M | $145.3M |
| Q4 25 | — | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | $229.8M | $2.0B | ||
| Q3 25 | $225.7M | — | ||
| Q2 25 | $226.0M | $1.9B | ||
| Q1 25 | $218.2M | $2.0B | ||
| Q4 24 | $214.4M | $2.1B | ||
| Q3 24 | $212.4M | $2.1B | ||
| Q2 24 | $209.4M | $2.1B | ||
| Q1 24 | $206.0M | $2.0B |
| Q4 25 | $439.4M | $2.5B | ||
| Q3 25 | $445.3M | — | ||
| Q2 25 | $426.8M | $2.6B | ||
| Q1 25 | $414.5M | $2.6B | ||
| Q4 24 | $386.8M | $2.7B | ||
| Q3 24 | $375.3M | $2.7B | ||
| Q2 24 | $371.2M | $2.7B | ||
| Q1 24 | $364.0M | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.4M | — |
| Free Cash FlowOCF − Capex | $11.6M | — |
| FCF MarginFCF / Revenue | 5.0% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | 2.33× | — |
| TTM Free Cash FlowTrailing 4 quarters | $8.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.4M | — | ||
| Q3 25 | $2.5M | — | ||
| Q2 25 | $3.1M | $98.2M | ||
| Q1 25 | $-5.7M | $41.1M | ||
| Q4 24 | $15.7M | $84.3M | ||
| Q3 24 | $205.0K | $63.9M | ||
| Q2 24 | $1.3M | $75.5M | ||
| Q1 24 | $3.9M | $81.0M |
| Q4 25 | $11.6M | — | ||
| Q3 25 | $977.0K | — | ||
| Q2 25 | $2.2M | $93.3M | ||
| Q1 25 | $-6.4M | $31.0M | ||
| Q4 24 | $14.1M | $77.5M | ||
| Q3 24 | $-1.9M | $54.7M | ||
| Q2 24 | $-185.0K | $57.5M | ||
| Q1 24 | $1.8M | $64.5M |
| Q4 25 | 5.0% | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 1.0% | 29.4% | ||
| Q1 25 | -3.0% | 9.8% | ||
| Q4 24 | 5.3% | 26.1% | ||
| Q3 24 | -0.9% | 18.9% | ||
| Q2 24 | -0.1% | 18.8% | ||
| Q1 24 | 1.0% | 21.3% |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | 0.4% | 1.5% | ||
| Q1 25 | 0.3% | 3.2% | ||
| Q4 24 | 0.6% | 2.3% | ||
| Q3 24 | 1.0% | 3.2% | ||
| Q2 24 | 0.7% | 5.9% | ||
| Q1 24 | 1.2% | 5.4% |
| Q4 25 | 2.33× | — | ||
| Q3 25 | 1.90× | — | ||
| Q2 25 | 0.63× | — | ||
| Q1 25 | -2.26× | 1.82× | ||
| Q4 24 | 2.43× | 2.42× | ||
| Q3 24 | 0.06× | 1.90× | ||
| Q2 24 | 0.26× | 1.86× | ||
| Q1 24 | — | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RLGT
| Transferred Over Time | $201.2M | 87% |
| Other | $25.0M | 11% |
| Value Added Services | $4.2M | 2% |
| Transferred At Point In Time | $1.8M | 1% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
